A successful 2025 financial year
DR Swiss looks back on a successful financial year 2025, closing the year with a profit after tax of CHF 7.1 million. Over the course of the year, gross written premiums increased by 7.8% to CHF 396.3 million, up from CHF 367.6 million in the previous year.
In market business, premium income rose modestly by 1.4% to CHF 273.2 million, compared with CHF 269.4 million in the prior year. This increase was driven primarily by growth in France and Spain.
Premium volume in continuity reinsurance increased significantly by 25.2% to CHF 123.0 million. This growth was attributable in particular to the expansion of existing business relationships.
The European insurance market developed positively during the financial year. Claims experience in both liability and property insurance remained below expectations.
In a year without major natural catastrophe losses, gross original claims expenditure fell by 8.2% to CHF 178.5 million. As a result, the loss ratio improved once again, declining from 55.4% to 46.5%.
Having reported a technical loss before own administrative expenses of CHF 2.6 million in the previous year, DR Swiss generated net income of CHF 2.0 million in the financial year 2025.
DR Swiss also continued to benefit from a positive investment result. Following the allocation to investment reserves, the company reported investment income of CHF 19.4 million and further earned CHF 2.2 million in interest income on liquid funds.
A partner with strong capitalisation
In 2025, the rating agency Standard & Poor’s once again affirmed the Deutsche Rück Group’s “A+” rating with a stable outlook, which also applies to DR Swiss. In Standard & Poor’s assessment, the Deutsche Rück Group benefits from very strong capitalisation, a strong competitive position and a sound earnings profile.
Developement of GPE 2021 - 2025
in CHF million
Investment
Performance 2021 - 2025
in CHF million (inkl. Cash deposits)
